Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination

Jenny-Avital, Elizabeth R.; Howe, Ruth A.

doi:10.3201/eid2805.212316

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination

5 2022
By Jenny-Avital, Elizabeth R. ; Howe, Ruth A.
http://dx.doi.org/10.3201/eid2805.212316
Source: Emerg Infect Dis. 2022; 28(5):1017-1020

[PDF-710.35 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Jenny-Avital, Elizabeth R. ; Howe, Ruth A.

Jenny-Avital, Elizabeth R. ; Howe, Ruth A. Less -
Description:

We observed multisystem inflammatory syndrome in 2 older adults in the United States who had received mRNA coronavirus disease vaccine soon after natural infection. We identified 5 similar cases from the Vaccine Adverse Events Reporting System. The timing of vaccination soon after natural infection might have an adverse effect on the occurrence of vaccine-related systemic inflammatory disorders.
Subjects:

[+]

Aged Covid-19 Vaccines/Adverse Effects Covid-19/Prevention & Control Drug-Related Side Effects And Adverse Reactions Humans Sars-Cov-2 Systemic Inflammatory Response Syndrome Vaccination/Adverse Effects
Source:

Emerg Infect Dis. 2022; 28(5):1017-1020
Pubmed ID:

35320702
Pubmed Central ID:

PMC9045437
Document Type:

Journal Article
Place as Subject:

United States
Volume:

28
Issue:

5
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:a15009426808d48ee5b59a0245a5d73f796216dfda9b52c9cff4e42e5ba6dabf
Download URL:

https://stacks.cdc.gov/view/cdc/117293/cdc_117293_DS1.pdf
File Type:

21-2316.nxml

xml

More +